 | • レポートコード：MRC2-11QY12410 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、155ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はインターベンショナルオンコロジーのグローバル市場について調査・分析したレポートです。種類別（放射線療法、アブレーション、粒子塞栓術）市場規模、用途別（肝臓がん、肺がん、腎臓がん、骨がん、乳がん、前立腺がん、膵臓がん）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別インターベンショナルオンコロジーの競争状況、市場シェア ・世界のインターベンショナルオンコロジー市場：種類別市場規模 2015年-2020年（放射線療法、アブレーション、粒子塞栓術） ・世界のインターベンショナルオンコロジー市場：種類別市場規模予測 2021年-2026年（放射線療法、アブレーション、粒子塞栓術） ・世界のインターベンショナルオンコロジー市場：用途別市場規模 2015年-2020年（肝臓がん、肺がん、腎臓がん、骨がん、乳がん、前立腺がん、膵臓がん） ・世界のインターベンショナルオンコロジー市場：用途別市場規模予測 2021年-2026年（肝臓がん、肺がん、腎臓がん、骨がん、乳がん、前立腺がん、膵臓がん） ・北米のインターベンショナルオンコロジー市場分析：米国、カナダ ・ヨーロッパのインターベンショナルオンコロジー市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのインターベンショナルオンコロジー市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のインターベンショナルオンコロジー市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのインターベンショナルオンコロジー市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Boston Scientific、BTG、Medtronic、Merit Medical、Terumo、Accuray、Alpinion Medical Systems、Angiodynamics、Atricure、Baylis Medical、Bovie Medical、Brainlab、Bsd Medical、C. R. Bard、C2 Therapeutics、Cardiofocus、Cook Medical、Eckert And Ziegler Bebig、Edap Tms、Elekta、Galil Medical、Healthtronics、Insightec、Medwaves、Mermaid Medical、Microsulis Medical、Monteris Medical ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Interventional oncology is a subspecialty field of interventional radiology that deals with the diagnosis and treatment of cancerand cancer-related problems using targeted minimally invasive procedures performed under image guidance.
Interventional oncology has developed to a separate pillar of modern oncology and it employs X-ray, ultrasound, computed tomography (CT) or magnetic resonance imaging (MRI) to help guide miniaturized instruments (e.g. biopsy needles, ablation electrodes, intravascular catheters) to allow targeted and precise treatment of solid tumours located in various organs of the human body, including but not limited to the liver, kidneys, lungs, and bones. Interventional oncology treatments are routinely carried out by interventional radiologists in appropriate settings and facilities.
Market Analysis and Insights: Global Interventional Oncology Market
The global Interventional Oncology market size is projected to reach US$ 1741.5 million by 2026, from US$ 1671.8 million in 2020, at a CAGR of 3.9%% during 2021-2026.
Global Interventional Oncology Scope and Market Size
Interventional Oncology market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Interventional Oncology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Boston Scientific
BTG
Medtronic
Merit Medical
Terumo
Accuray
Alpinion Medical Systems
Angiodynamics
Atricure
Baylis Medical
Bovie Medical
Brainlab
Bsd Medical
C. R. Bard
C2 Therapeutics
Cardiofocus
Cook Medical
Eckert And Ziegler Bebig
Edap Tms
Elekta
Galil Medical
Healthtronics
Insightec
Medwaves
Mermaid Medical
Microsulis Medical
Monteris Medical
Market segment by Type, the product can be split into
Radiation Therapy
Ablation
Particle Embolization
Market segment by Application, split into
Liver Cancer
Lung Cancer
Kidney Cancer
Bone Cancer
Breast Cancer
Prostate Cancer
Pancreatic Cancer
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Interventional Oncology Revenue
1.4 Market by Type
1.4.1 Global Interventional Oncology Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Radiation Therapy
1.4.3 Ablation
1.4.4 Particle Embolization
1.5 Market by Application
1.5.1 Global Interventional Oncology Market Share by Application: 2020 VS 2026
1.5.2 Liver Cancer
1.5.3 Lung Cancer
1.5.4 Kidney Cancer
1.5.5 Bone Cancer
1.5.6 Breast Cancer
1.5.7 Prostate Cancer
1.5.8 Pancreatic Cancer
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Interventional Oncology Market Perspective (2015-2026)
2.2 Global Interventional Oncology Growth Trends by Regions
2.2.1 Interventional Oncology Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Interventional Oncology Historic Market Share by Regions (2015-2020)
2.2.3 Interventional Oncology Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Interventional Oncology Market Growth Strategy
2.3.6 Primary Interviews with Key Interventional Oncology Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Interventional Oncology Players by Market Size
3.1.1 Global Top Interventional Oncology Players by Revenue (2015-2020)
3.1.2 Global Interventional Oncology Revenue Market Share by Players (2015-2020)
3.1.3 Global Interventional Oncology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Interventional Oncology Market Concentration Ratio
3.2.1 Global Interventional Oncology Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Interventional Oncology Revenue in 2019
3.3 Interventional Oncology Key Players Head office and Area Served
3.4 Key Players Interventional Oncology Product Solution and Service
3.5 Date of Enter into Interventional Oncology Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Interventional Oncology Historic Market Size by Type (2015-2020)
4.2 Global Interventional Oncology Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Interventional Oncology Market Size by Application (2015-2020)
5.2 Global Interventional Oncology Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Interventional Oncology Market Size (2015-2020)
6.2 Interventional Oncology Key Players in North America (2019-2020)
6.3 North America Interventional Oncology Market Size by Type (2015-2020)
6.4 North America Interventional Oncology Market Size by Application (2015-2020)
7 Europe
7.1 Europe Interventional Oncology Market Size (2015-2020)
7.2 Interventional Oncology Key Players in Europe (2019-2020)
7.3 Europe Interventional Oncology Market Size by Type (2015-2020)
7.4 Europe Interventional Oncology Market Size by Application (2015-2020)
8 China
8.1 China Interventional Oncology Market Size (2015-2020)
8.2 Interventional Oncology Key Players in China (2019-2020)
8.3 China Interventional Oncology Market Size by Type (2015-2020)
8.4 China Interventional Oncology Market Size by Application (2015-2020)
9 Japan
9.1 Japan Interventional Oncology Market Size (2015-2020)
9.2 Interventional Oncology Key Players in Japan (2019-2020)
9.3 Japan Interventional Oncology Market Size by Type (2015-2020)
9.4 Japan Interventional Oncology Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Interventional Oncology Market Size (2015-2020)
10.2 Interventional Oncology Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Interventional Oncology Market Size by Type (2015-2020)
10.4 Southeast Asia Interventional Oncology Market Size by Application (2015-2020)
11 India
11.1 India Interventional Oncology Market Size (2015-2020)
11.2 Interventional Oncology Key Players in India (2019-2020)
11.3 India Interventional Oncology Market Size by Type (2015-2020)
11.4 India Interventional Oncology Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Interventional Oncology Market Size (2015-2020)
12.2 Interventional Oncology Key Players in Central & South America (2019-2020)
12.3 Central & South America Interventional Oncology Market Size by Type (2015-2020)
12.4 Central & South America Interventional Oncology Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Boston Scientific
13.1.1 Boston Scientific Company Details
13.1.2 Boston Scientific Business Overview
13.1.3 Boston Scientific Interventional Oncology Introduction
13.1.4 Boston Scientific Revenue in Interventional Oncology Business (2015-2020))
13.1.5 Boston Scientific Recent Development
13.2 BTG
13.2.1 BTG Company Details
13.2.2 BTG Business Overview
13.2.3 BTG Interventional Oncology Introduction
13.2.4 BTG Revenue in Interventional Oncology Business (2015-2020)
13.2.5 BTG Recent Development
13.3 Medtronic
13.3.1 Medtronic Company Details
13.3.2 Medtronic Business Overview
13.3.3 Medtronic Interventional Oncology Introduction
13.3.4 Medtronic Revenue in Interventional Oncology Business (2015-2020)
13.3.5 Medtronic Recent Development
13.4 Merit Medical
13.4.1 Merit Medical Company Details
13.4.2 Merit Medical Business Overview
13.4.3 Merit Medical Interventional Oncology Introduction
13.4.4 Merit Medical Revenue in Interventional Oncology Business (2015-2020)
13.4.5 Merit Medical Recent Development
13.5 Terumo
13.5.1 Terumo Company Details
13.5.2 Terumo Business Overview
13.5.3 Terumo Interventional Oncology Introduction
13.5.4 Terumo Revenue in Interventional Oncology Business (2015-2020)
13.5.5 Terumo Recent Development
13.6 Accuray
13.6.1 Accuray Company Details
13.6.2 Accuray Business Overview
13.6.3 Accuray Interventional Oncology Introduction
13.6.4 Accuray Revenue in Interventional Oncology Business (2015-2020)
13.6.5 Accuray Recent Development
13.7 Alpinion Medical Systems
13.7.1 Alpinion Medical Systems Company Details
13.7.2 Alpinion Medical Systems Business Overview
13.7.3 Alpinion Medical Systems Interventional Oncology Introduction
13.7.4 Alpinion Medical Systems Revenue in Interventional Oncology Business (2015-2020)
13.7.5 Alpinion Medical Systems Recent Development
13.8 Angiodynamics
13.8.1 Angiodynamics Company Details
13.8.2 Angiodynamics Business Overview
13.8.3 Angiodynamics Interventional Oncology Introduction
13.8.4 Angiodynamics Revenue in Interventional Oncology Business (2015-2020)
13.8.5 Angiodynamics Recent Development
13.9 Atricure
13.9.1 Atricure Company Details
13.9.2 Atricure Business Overview
13.9.3 Atricure Interventional Oncology Introduction
13.9.4 Atricure Revenue in Interventional Oncology Business (2015-2020)
13.9.5 Atricure Recent Development
13.10 Baylis Medical
13.10.1 Baylis Medical Company Details
13.10.2 Baylis Medical Business Overview
13.10.3 Baylis Medical Interventional Oncology Introduction
13.10.4 Baylis Medical Revenue in Interventional Oncology Business (2015-2020)
13.10.5 Baylis Medical Recent Development
13.11 Bovie Medical
10.11.1 Bovie Medical Company Details
10.11.2 Bovie Medical Business Overview
10.11.3 Bovie Medical Interventional Oncology Introduction
10.11.4 Bovie Medical Revenue in Interventional Oncology Business (2015-2020)
10.11.5 Bovie Medical Recent Development
13.12 Brainlab
10.12.1 Brainlab Company Details
10.12.2 Brainlab Business Overview
10.12.3 Brainlab Interventional Oncology Introduction
10.12.4 Brainlab Revenue in Interventional Oncology Business (2015-2020)
10.12.5 Brainlab Recent Development
13.13 Bsd Medical
10.13.1 Bsd Medical Company Details
10.13.2 Bsd Medical Business Overview
10.13.3 Bsd Medical Interventional Oncology Introduction
10.13.4 Bsd Medical Revenue in Interventional Oncology Business (2015-2020)
10.13.5 Bsd Medical Recent Development
13.14 C. R. Bard
10.14.1 C. R. Bard Company Details
10.14.2 C. R. Bard Business Overview
10.14.3 C. R. Bard Interventional Oncology Introduction
10.14.4 C. R. Bard Revenue in Interventional Oncology Business (2015-2020)
10.14.5 C. R. Bard Recent Development
13.15 C2 Therapeutics
10.15.1 C2 Therapeutics Company Details
10.15.2 C2 Therapeutics Business Overview
10.15.3 C2 Therapeutics Interventional Oncology Introduction
10.15.4 C2 Therapeutics Revenue in Interventional Oncology Business (2015-2020)
10.15.5 C2 Therapeutics Recent Development
13.16 Cardiofocus
10.16.1 Cardiofocus Company Details
10.16.2 Cardiofocus Business Overview
10.16.3 Cardiofocus Interventional Oncology Introduction
10.16.4 Cardiofocus Revenue in Interventional Oncology Business (2015-2020)
10.16.5 Cardiofocus Recent Development
13.17 Cook Medical
10.17.1 Cook Medical Company Details
10.17.2 Cook Medical Business Overview
10.17.3 Cook Medical Interventional Oncology Introduction
10.17.4 Cook Medical Revenue in Interventional Oncology Business (2015-2020)
10.17.5 Cook Medical Recent Development
13.18 Eckert And Ziegler Bebig
10.18.1 Eckert And Ziegler Bebig Company Details
10.18.2 Eckert And Ziegler Bebig Business Overview
10.18.3 Eckert And Ziegler Bebig Interventional Oncology Introduction
10.18.4 Eckert And Ziegler Bebig Revenue in Interventional Oncology Business (2015-2020)
10.18.5 Eckert And Ziegler Bebig Recent Development
13.19 Edap Tms
10.19.1 Edap Tms Company Details
10.19.2 Edap Tms Business Overview
10.19.3 Edap Tms Interventional Oncology Introduction
10.19.4 Edap Tms Revenue in Interventional Oncology Business (2015-2020)
10.19.5 Edap Tms Recent Development
13.20 Elekta
10.20.1 Elekta Company Details
10.20.2 Elekta Business Overview
10.20.3 Elekta Interventional Oncology Introduction
10.20.4 Elekta Revenue in Interventional Oncology Business (2015-2020)
10.20.5 Elekta Recent Development
13.21 Galil Medical
10.21.1 Galil Medical Company Details
10.21.2 Galil Medical Business Overview
10.21.3 Galil Medical Interventional Oncology Introduction
10.21.4 Galil Medical Revenue in Interventional Oncology Business (2015-2020)
10.21.5 Galil Medical Recent Development
13.22 Healthtronics
10.22.1 Healthtronics Company Details
10.22.2 Healthtronics Business Overview
10.22.3 Healthtronics Interventional Oncology Introduction
10.22.4 Healthtronics Revenue in Interventional Oncology Business (2015-2020)
10.22.5 Healthtronics Recent Development
13.23 Insightec
10.23.1 Insightec Company Details
10.23.2 Insightec Business Overview
10.23.3 Insightec Interventional Oncology Introduction
10.23.4 Insightec Revenue in Interventional Oncology Business (2015-2020)
10.23.5 Insightec Recent Development
13.24 Medwaves
10.24.1 Medwaves Company Details
10.24.2 Medwaves Business Overview
10.24.3 Medwaves Interventional Oncology Introduction
10.24.4 Medwaves Revenue in Interventional Oncology Business (2015-2020)
10.24.5 Medwaves Recent Development
13.25 Mermaid Medical
10.25.1 Mermaid Medical Company Details
10.25.2 Mermaid Medical Business Overview
10.25.3 Mermaid Medical Interventional Oncology Introduction
10.25.4 Mermaid Medical Revenue in Interventional Oncology Business (2015-2020)
10.25.5 Mermaid Medical Recent Development
13.26 Microsulis Medical
10.26.1 Microsulis Medical Company Details
10.26.2 Microsulis Medical Business Overview
10.26.3 Microsulis Medical Interventional Oncology Introduction
10.26.4 Microsulis Medical Revenue in Interventional Oncology Business (2015-2020)
10.26.5 Microsulis Medical Recent Development
13.27 Monteris Medical
10.27.1 Monteris Medical Company Details
10.27.2 Monteris Medical Business Overview
10.27.3 Monteris Medical Interventional Oncology Introduction
10.27.4 Monteris Medical Revenue in Interventional Oncology Business (2015-2020)
10.27.5 Monteris Medical Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Interventional Oncology Key Market Segments
Table 2. Key Players Covered: Ranking by Interventional Oncology Revenue
Table 3. Ranking of Global Top Interventional Oncology Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Interventional Oncology Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Radiation Therapy
Table 6. Key Players of Ablation
Table 7. Key Players of Particle Embolization
Table 8. Global Interventional Oncology Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Interventional Oncology Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Interventional Oncology Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Interventional Oncology Market Share by Regions (2015-2020)
Table 12. Global Interventional Oncology Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Interventional Oncology Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Interventional Oncology Market Growth Strategy
Table 18. Main Points Interviewed from Key Interventional Oncology Players
Table 19. Global Interventional Oncology Revenue by Players (2015-2020) (Million US$)
Table 20. Global Interventional Oncology Market Share by Players (2015-2020)
Table 21. Global Top Interventional Oncology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Interventional Oncology as of 2019)
Table 22. Global Interventional Oncology by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Interventional Oncology Product Solution and Service
Table 25. Date of Enter into Interventional Oncology Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Interventional Oncology Market Size by Type (2015-2020) (Million US$)
Table 28. Global Interventional Oncology Market Size Share by Type (2015-2020)
Table 29. Global Interventional Oncology Revenue Market Share by Type (2021-2026)
Table 30. Global Interventional Oncology Market Size Share by Application (2015-2020)
Table 31. Global Interventional Oncology Market Size by Application (2015-2020) (Million US$)
Table 32. Global Interventional Oncology Market Size Share by Application (2021-2026)
Table 33. North America Key Players Interventional Oncology Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Interventional Oncology Market Share (2019-2020)
Table 35. North America Interventional Oncology Market Size by Type (2015-2020) (Million US$)
Table 36. North America Interventional Oncology Market Share by Type (2015-2020)
Table 37. North America Interventional Oncology Market Size by Application (2015-2020) (Million US$)
Table 38. North America Interventional Oncology Market Share by Application (2015-2020)
Table 39. Europe Key Players Interventional Oncology Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Interventional Oncology Market Share (2019-2020)
Table 41. Europe Interventional Oncology Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Interventional Oncology Market Share by Type (2015-2020)
Table 43. Europe Interventional Oncology Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Interventional Oncology Market Share by Application (2015-2020)
Table 45. China Key Players Interventional Oncology Revenue (2019-2020) (Million US$)
Table 46. China Key Players Interventional Oncology Market Share (2019-2020)
Table 47. China Interventional Oncology Market Size by Type (2015-2020) (Million US$)
Table 48. China Interventional Oncology Market Share by Type (2015-2020)
Table 49. China Interventional Oncology Market Size by Application (2015-2020) (Million US$)
Table 50. China Interventional Oncology Market Share by Application (2015-2020)
Table 51. Japan Key Players Interventional Oncology Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Interventional Oncology Market Share (2019-2020)
Table 53. Japan Interventional Oncology Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Interventional Oncology Market Share by Type (2015-2020)
Table 55. Japan Interventional Oncology Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Interventional Oncology Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Interventional Oncology Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Interventional Oncology Market Share (2019-2020)
Table 59. Southeast Asia Interventional Oncology Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Interventional Oncology Market Share by Type (2015-2020)
Table 61. Southeast Asia Interventional Oncology Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Interventional Oncology Market Share by Application (2015-2020)
Table 63. India Key Players Interventional Oncology Revenue (2019-2020) (Million US$)
Table 64. India Key Players Interventional Oncology Market Share (2019-2020)
Table 65. India Interventional Oncology Market Size by Type (2015-2020) (Million US$)
Table 66. India Interventional Oncology Market Share by Type (2015-2020)
Table 67. India Interventional Oncology Market Size by Application (2015-2020) (Million US$)
Table 68. India Interventional Oncology Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Interventional Oncology Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Interventional Oncology Market Share (2019-2020)
Table 71. Central & South America Interventional Oncology Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Interventional Oncology Market Share by Type (2015-2020)
Table 73. Central & South America Interventional Oncology Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Interventional Oncology Market Share by Application (2015-2020)
Table 75. Boston Scientific Company Details
Table 76. Boston Scientific Business Overview
Table 77. Boston Scientific Product
Table 78. Boston Scientific Revenue in Interventional Oncology Business (2015-2020) (Million US$)
Table 79. Boston Scientific Recent Development
Table 80. BTG Company Details
Table 81. BTG Business Overview
Table 82. BTG Product
Table 83. BTG Revenue in Interventional Oncology Business (2015-2020) (Million US$)
Table 84. BTG Recent Development
Table 85. Medtronic Company Details
Table 86. Medtronic Business Overview
Table 87. Medtronic Product
Table 88. Medtronic Revenue in Interventional Oncology Business (2015-2020) (Million US$)
Table 89. Medtronic Recent Development
Table 90. Merit Medical Company Details
Table 91. Merit Medical Business Overview
Table 92. Merit Medical Product
Table 93. Merit Medical Revenue in Interventional Oncology Business (2015-2020) (Million US$)
Table 94. Merit Medical Recent Development
Table 95. Terumo Company Details
Table 96. Terumo Business Overview
Table 97. Terumo Product
Table 98. Terumo Revenue in Interventional Oncology Business (2015-2020) (Million US$)
Table 99. Terumo Recent Development
Table 100. Accuray Company Details
Table 101. Accuray Business Overview
Table 102. Accuray Product
Table 103. Accuray Revenue in Interventional Oncology Business (2015-2020) (Million US$)
Table 104. Accuray Recent Development
Table 105. Alpinion Medical Systems Company Details
Table 106. Alpinion Medical Systems Business Overview
Table 107. Alpinion Medical Systems Product
Table 108. Alpinion Medical Systems Revenue in Interventional Oncology Business (2015-2020) (Million US$)
Table 109. Alpinion Medical Systems Recent Development
Table 110. Angiodynamics Business Overview
Table 111. Angiodynamics Product
Table 112. Angiodynamics Company Details
Table 113. Angiodynamics Revenue in Interventional Oncology Business (2015-2020) (Million US$)
Table 114. Angiodynamics Recent Development
Table 115. Atricure Company Details
Table 116. Atricure Business Overview
Table 117. Atricure Product
Table 118. Atricure Revenue in Interventional Oncology Business (2015-2020) (Million US$)
Table 119. Atricure Recent Development
Table 120. Baylis Medical Company Details
Table 121. Baylis Medical Business Overview
Table 122. Baylis Medical Product
Table 123. Baylis Medical Revenue in Interventional Oncology Business (2015-2020) (Million US$)
Table 124. Baylis Medical Recent Development
Table 125. Bovie Medical Company Details
Table 126. Bovie Medical Business Overview
Table 127. Bovie Medical Product
Table 128. Bovie Medical Revenue in Interventional Oncology Business (2015-2020) (Million US$)
Table 129. Bovie Medical Recent Development
Table 130. Brainlab Company Details
Table 131. Brainlab Business Overview
Table 132. Brainlab Product
Table 133. Brainlab Revenue in Interventional Oncology Business (2015-2020) (Million US$)
Table 134. Brainlab Recent Development
Table 135. Bsd Medical Company Details
Table 136. Bsd Medical Business Overview
Table 137. Bsd Medical Product
Table 138. Bsd Medical Revenue in Interventional Oncology Business (2015-2020) (Million US$)
Table 139. Bsd Medical Recent Development
Table 140. C. R. Bard Company Details
Table 141. C. R. Bard Business Overview
Table 142. C. R. Bard Product
Table 143. C. R. Bard Revenue in Interventional Oncology Business (2015-2020) (Million US$)
Table 144. C. R. Bard Recent Development
Table 145. C2 Therapeutics Company Details
Table 146. C2 Therapeutics Business Overview
Table 147. C2 Therapeutics Product
Table 148. C2 Therapeutics Revenue in Interventional Oncology Business (2015-2020) (Million US$)
Table 149. C2 Therapeutics Recent Development
Table 150. Cardiofocus Company Details
Table 151. Cardiofocus Business Overview
Table 152. Cardiofocus Product
Table 153. Cardiofocus Revenue in Interventional Oncology Business (2015-2020) (Million US$)
Table 154. Cardiofocus Recent Development
Table 155. Cook Medical Company Details
Table 156. Cook Medical Business Overview
Table 157. Cook Medical Product
Table 158. Cook Medical Revenue in Interventional Oncology Business (2015-2020) (Million US$)
Table 159. Cook Medical Recent Development
Table 160. Eckert And Ziegler Bebig Company Details
Table 161. Eckert And Ziegler Bebig Business Overview
Table 162. Eckert And Ziegler Bebig Product
Table 163. Eckert And Ziegler Bebig Revenue in Interventional Oncology Business (2015-2020) (Million US$)
Table 164. Eckert And Ziegler Bebig Recent Development
Table 165. Edap Tms Company Details
Table 166. Edap Tms Business Overview
Table 167. Edap Tms Product
Table 168. Edap Tms Revenue in Interventional Oncology Business (2015-2020) (Million US$)
Table 169. Edap Tms Recent Development
Table 170. Elekta Company Details
Table 171. Elekta Business Overview
Table 172. Elekta Product
Table 173. Elekta Revenue in Interventional Oncology Business (2015-2020) (Million US$)
Table 174. Elekta Recent Development
Table 175. Galil Medical Company Details
Table 176. Galil Medical Business Overview
Table 177. Galil Medical Product
Table 178. Galil Medical Revenue in Interventional Oncology Business (2015-2020) (Million US$)
Table 179. Galil Medical Recent Development
Table 180. Healthtronics Company Details
Table 181. Healthtronics Business Overview
Table 182. Healthtronics Product
Table 183. Healthtronics Revenue in Interventional Oncology Business (2015-2020) (Million US$)
Table 184. Healthtronics Recent Development
Table 185. Insightec Company Details
Table 186. Insightec Business Overview
Table 187. Insightec Product
Table 188. Insightec Revenue in Interventional Oncology Business (2015-2020) (Million US$)
Table 189. Insightec Recent Development
Table 190. Medwaves Company Details
Table 191. Medwaves Business Overview
Table 192. Medwaves Product
Table 193. Medwaves Revenue in Interventional Oncology Business (2015-2020) (Million US$)
Table 194. Medwaves Recent Development
Table 195. Mermaid Medical Company Details
Table 196. Mermaid Medical Business Overview
Table 197. Mermaid Medical Product
Table 198. Mermaid Medical Revenue in Interventional Oncology Business (2015-2020) (Million US$)
Table 199. Mermaid Medical Recent Development
Table 200. Microsulis Medical Company Details
Table 201. Microsulis Medical Business Overview
Table 202. Microsulis Medical Product
Table 203. Microsulis Medical Revenue in Interventional Oncology Business (2015-2020) (Million US$)
Table 204. Microsulis Medical Recent Development
Table 205. Monteris Medical Company Details
Table 206. Monteris Medical Business Overview
Table 207. Monteris Medical Product
Table 208. Monteris Medical Revenue in Interventional Oncology Business (2015-2020) (Million US$)
Table 209. Monteris Medical Recent Development
Table 210. Research Programs/Design for This Report
Table 211. Key Data Information from Secondary Sources
Table 212. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Interventional Oncology Market Share by Type: 2020 VS 2026
Figure 2. Radiation Therapy Features
Figure 3. Ablation Features
Figure 4. Particle Embolization Features
Figure 5. Global Interventional Oncology Market Share by Application: 2020 VS 2026
Figure 6. Liver Cancer Case Studies
Figure 7. Lung Cancer Case Studies
Figure 8. Kidney Cancer Case Studies
Figure 9. Bone Cancer Case Studies
Figure 10. Breast Cancer Case Studies
Figure 11. Prostate Cancer Case Studies
Figure 12. Pancreatic Cancer Case Studies
Figure 13. Interventional Oncology Report Years Considered
Figure 14. Global Interventional Oncology Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global Interventional Oncology Market Share by Regions: 2020 VS 2026
Figure 16. Global Interventional Oncology Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Interventional Oncology Market Share by Players in 2019
Figure 19. Global Top Interventional Oncology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Interventional Oncology as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Interventional Oncology Revenue in 2019
Figure 21. North America Interventional Oncology Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe Interventional Oncology Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China Interventional Oncology Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan Interventional Oncology Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Southeast Asia Interventional Oncology Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. India Interventional Oncology Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Central & South America Interventional Oncology Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Bottom-up and Top-down Approaches for This Report
Figure 29. Data Triangulation
Figure 30. Key Executives Interviewed
放射線腫瘍学の世界市場（～2026年） Market Analysis and Insights: Global Radiation Oncology Market The global Radiation Oncology market size is projected to reach US$ 5491.5 million by 2026, from US$ 5199.5 million in 2020, at a CAGR of 5.2%% during 2021-2026. Global Radiation Oncology Scope and Market Size Radiation Oncology market i…- 膵臓がん治療の世界市場（～2026年） Pancreatic cancer therapy is recommended by clinicians for early detection of cancer. Pancreatic cancer generally diagnosed at a later stage, since the symptoms are not easily detected or diagnosed. Factors such as, chronic inflammation of the pancreas (pancreatitis), diabetes, smoking, and obesity …
- 腫瘍学/がん治療薬の世界市場（～2026年） Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others. Oncology Drugs is widely used For Blood Cancer, Breast Cancer, Gastroint…
- 腫瘍栄養学の世界市場（～2026年） Cancers are among the leading causes of morbidity and mortality worldwide, and the number of new cases is expected to rise significantly over the next decades. Nutritional oncology is an increasingly active interdisciplinary field where cancer is investigated as both a systemic and local disease ori…
- 小細胞肺がん治療薬の世界市場（～2026年） Lung cancer can be categorized into two types: non-small cell lung cancer and small cell lung cancer. Small cell lung cancer constitutes roughly 10-15 percent of all diagnosed cases of lung cancer. Small cell lung cancer is categorized into two types: small cell carcinoma and combined small cell car…